Southeast Asset Advisors LLC Purchases Shares of 4,549 Colgate-Palmolive Company $CL

Key Points

• Southeast Asset Advisors LLC acquired a new stake in Colgate-Palmolive Company, purchasing 4,549 shares valued at approximately $426,000 during the first quarter.
• The company reported a 1.0% increase in revenue year-over-year for the latest quarter, with earnings of $0.92 per share, surpassing analysts' expectations.
• Colgate-Palmolive announced a quarterly dividend of $0.52, marking a 2.4% yield, with a payout ratio currently at 58.43%.

Southeast Asset Advisors LLC purchased a new stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 4,549 shares of the company's stock, valued at approximately $426,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Sax Wealth Advisors LLC increased its holdings in Colgate-Palmolive by 3.5% during the 1st quarter. Sax Wealth Advisors LLC now owns 23,560 shares of the company's stock worth $2,208,000 after acquiring an additional 796 shares during the period. Van Hulzen Asset Management LLC increased its holdings in Colgate-Palmolive by 14.1% during the 1st quarter. Van Hulzen Asset Management LLC now owns 2,228 shares of the company's stock worth $209,000 after acquiring an additional 276 shares during the period. Allstate Corp increased its holdings in Colgate-Palmolive by 65.8% during the 1st quarter. Allstate Corp now owns 38,063 shares of the company's stock worth $3,567,000 after acquiring an additional 15,104 shares during the period. 1832 Asset Management L.P. increased its holdings in Colgate-Palmolive by 403.0% during the 1st quarter. 1832 Asset Management L.P. now owns 46,785 shares of the company's stock worth $4,384,000 after acquiring an additional 37,484 shares during the period. Finally, Compound Planning Inc. increased its holdings in Colgate-Palmolive by 5.7% during the 1st quarter. Compound Planning Inc. now owns 6,857 shares of the company's stock worth $642,000 after acquiring an additional 368 shares during the period. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 0.6%

Shares of CL stock traded up $0.48 on Friday, hitting $83.90. 1,574,775 shares of the company's stock traded hands, compared to its average volume of 5,193,989. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. Colgate-Palmolive Company has a one year low of $82.40 and a one year high of $109.30. The company's fifty day simple moving average is $87.23 and its 200 day simple moving average is $89.85. The stock has a market capitalization of $67.81 billion, a price-to-earnings ratio of 23.58, a P/E/G ratio of 4.39 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same quarter last year, the firm earned $0.91 EPS. The firm's quarterly revenue was up 1.0% compared to the same quarter last year. Equities analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.5%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.43%.

Analyst Ratings Changes

A number of research firms recently weighed in on CL. Morgan Stanley decreased their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. UBS Group decreased their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Wall Street Zen lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. Barclays increased their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a report on Tuesday, July 15th. Finally, Citigroup decreased their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $98.92.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.